| 产品详情 |
| Edit |   |
|---|
| Product Name | Linagliptin |
|---|
| Description | A novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Alternate Names: 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; BI 1356; BI 1356BS; ONDERO |
|---|
| Size | 10mg, 100mg, 500mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; BI 1356; BI 1356BS; ONDERO |
|---|
| Gene, Accession, CAS # | CAS: 668270-12-0 |
|---|
| Catalog # | 15575 |
|---|
| Price | |
|---|
| Order / More Info | Linagliptin from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|